- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-IFNA1/ IFNA13 functional antibody
Anti-IFNA1/ IFNA13 functional antibody for cell culture, ELISA & in-vivo assay
Go to IFNA13/IFNA13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0977-Ab-1/ GM-Tg-hg-SE0977-Ab-2 | Anti-Human IFNA13 monoclonal antibody | Human |
| GM-Tg-rg-SE0977-Ab-1/ GM-Tg-rg-SE0977-Ab-2 | Anti-Rat IFNA13 monoclonal antibody | Rat |
| GM-Tg-mg-SE0977-Ab-1/ GM-Tg-mg-SE0977-Ab-2 | Anti-Mouse IFNA13 monoclonal antibody | Mouse |
| GM-Tg-cynog-SE0977-Ab-1/ GM-Tg-cynog-SE0977-Ab-2 | Anti-Cynomolgus/ Rhesus macaque IFNA13 monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0977-Ab-1/ GM-Tg-felg-SE0977-Ab-2 | Anti-Feline IFNA13 monoclonal antibody | Feline |
| GM-Tg-cang-SE0977-Ab-1/ GM-Tg-cang-SE0977-Ab-2 | Anti-Canine IFNA13 monoclonal antibody | Canine |
| GM-Tg-bovg-SE0977-Ab-1/ GM-Tg-bovg-SE0977-Ab-2 | Anti-Bovine IFNA13 monoclonal antibody | Bovine |
| GM-Tg-equg-SE0977-Ab-1/ GM-Tg-equg-SE0977-Ab-2 | Anti-Equine IFNA13 monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-SE0977-Ab-1/ GM-Tg-hg-SE0977-Ab-2; GM-Tg-rg-SE0977-Ab-1/ GM-Tg-rg-SE0977-Ab-2; GM-Tg-mg-SE0977-Ab-1/ GM-Tg-mg-SE0977-Ab-2; GM-Tg-cynog-SE0977-Ab-1/ GM-Tg-cynog-SE0977-Ab-2; GM-Tg-felg-SE0977-Ab-1/ GM-Tg-felg-SE0977-Ab-2; GM-Tg-cang-SE0977-Ab-1/ GM-Tg-cang-SE0977-Ab-2; GM-Tg-bovg-SE0977-Ab-1/ GM-Tg-bovg-SE0977-Ab-2; GM-Tg-equg-SE0977-Ab-1/ GM-Tg-equg-SE0977-Ab-2 |
| Products Name | Anti-IFNA13 monoclonal antibody |
| Format | mab |
| Target Name | IFNA13 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category of antibody | FACS/Biofunctional Antibody, Cytokine antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-IFNA13 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | GM-Tg-g-SE0977-Ag-1 | Recombinant multi-species IFNA1/ IFNA13 protein |
| Cytokine | GM-Tg-g-SE0977-Ag-1 | interferon, alpha 13 (IFNA13) protein |
| ORF Viral Vector | vGMLP000155 | human IFNA13 Lentivirus particle |
| ORF Viral Vector | pGMLP000155 | human IFNA13 Lentivirus plasmid |
Target information
| Target ID | GM-SE0977 |
| Target Name | IFNA13 |
| Gene ID | 3447 |
| Gene Symbol and Synonyms | IFNA13 |
| Uniprot Accession | P01562 |
| Uniprot Entry Name | IFNA1_HUMAN |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Cytokine Target |
| Disease | N/A |
| Gene Ensembl | ENSG00000233816 |
| Target Classification | N/A |
The target: IFNA13, gene name: IFNA13, also named as . Predicted to enable cytokine activity and type I interferon receptor binding activity. Predicted to be involved in several processes, including B cell activation; lymphocyte activation involved in immune response; and positive regulation of peptidyl-serine phosphorylation of STAT protein. Predicted to be located in extracellular region. Predicted to be active in extracellular space..
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
